Pharmaceutical compound
Methallatal is a barbiturate derivative first synthesized in the 1940s (designation V-12).[1][2] It has sedative and hypnotic properties.
Methallatal was formerly marketed under the trade name Mosidal from 1940s to 1950s for veterinary use, specifically for preventing motion sickness in dogs.[2]
References
- ^ Carson GB (1954). The barbiturates in forensic chemistry. Ohio State University. Retrieved 2026-02-11.
- ^ a b Elliott KA, Noble RL (September 1948). “Control of car sickness in a dog by V-12 (mosidal)”. Canadian Medical Association Journal. 59 (3): 277. PMC 1591212. PMID 18877437.